Proper training from healthcare professionals, correct injection technique, and regular site rotation are essential to prevent administration errors
You can read the abstract of this article at 679-P: The Novel GIP, GLP-1, and Glucagon Triple Receptor Agonist LY3437943 Exhibits Robust Efficacy in Preclinical Models of Obesity and Diabetes | Diabetes | American Diabetes Association (diabetesjournals.org)
When the medication is stopped, these effects cease and appetite increases again
Metabolism and Elimination: The prolonged half-life is the result of two key structural modifications: one that promotes strong binding to the blood protein albumin, which protects it from being filtered out by the kidneys, and another that makes it resistant to enzymatic degradation
Storage after reconstitution Once reconstituted, the clock starts ticking